Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 752643, 5 pages
Research Article

Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port

Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington, DC 20010, USA

Received 16 April 2012; Accepted 10 June 2012

Academic Editor: Pompiliu Piso

Copyright © 2012 Paul H. Sugarbaker and Lana Bijelic. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Paul H Sugarbaker, O Anthony Stuart, and Lana Bijelic, “Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data.,” International journal of surgical oncology, vol. 2011, pp. 161862, 2011. View at Publisher · View at Google Scholar
  • Afshin Amini, Samar Masoumi-Moghaddam, and David Lawson Morris, “Pseudomyxoma peritonei: current chemotherapy and the need for mucin-directed strategies,” Expert Opinion On Orphan Drugs, vol. 3, no. 2, pp. 183–193, 2015. View at Publisher · View at Google Scholar
  • A. F. Chernousov, T. V. Khorobrykh, D. V. Vychuzhanin, N. S. Kharlov, and R. Nurutdinov, “Subcutaneous port systems with intraperitoneal catheter «BBraun» in combined treatment of advanced stomach cancer,” Khirurgiya. Zhurnal im. N.I. Pirogova, no. 7, pp. 67, 2016. View at Publisher · View at Google Scholar
  • Paul H. Sugarbaker, “Strategies to improve local control of resected pancreas adenocarcinoma,” Surgical Oncology, vol. 26, no. 1, pp. 63–70, 2017. View at Publisher · View at Google Scholar
  • Paul H. Sugarbaker, and David Chang, “Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival,” European Journal of Surgical Oncology (EJSO), 2017. View at Publisher · View at Google Scholar